Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform

Completed

Conditions studied: Chronic Heart Failure

In brief

Medtronic is sponsoring the Apogee study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving a Medtronic HeartWare™ Ventricular Assist Device (HVAD™) for destination therapy. The Apogee study is conducted within Medtronic's Product Surveillance Platform.

Key facts

Study ID
NCT03697980
Run by
Medtronic Cardiac Rhythm and Heart Failure
People needed
136
Starts
2019-01-17
Expected to finish
2022-02-10
Last updated by the study team
2023-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.